Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Genocea Biosciences's accounts receivables for the quarter that ended in Mar. 2022 was $0.00 Mil.
Accounts receivable can be measured by Days Sales Outstanding.
Genocea Biosciences's Days Sales Outstanding for the quarter that ended in Mar. 2022 was 0.00.
In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Genocea Biosciences's Net-Net Working Capital per share for the quarter that ended in Mar. 2022 was $-0.11.
Genocea Biosciences Accounts Receivable Historical Data
The historical data trend for Genocea Biosciences's Accounts Receivable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
Genocea Biosciences's Days Sales Outstanding for the quarter that ended in Mar. 2022 is calculated as:
2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Genocea Biosciences's accounts receivable are only considered to be worth 75% of book value:
Genocea Biosciences's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2022 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.
If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.
Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.
Genocea Biosciences Accounts Receivable Related Terms
Thank you for viewing the detailed overview of Genocea Biosciences's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.
Genocea Biosciences (Genocea Biosciences) Business Description
Genocea Biosciences Inc is a US-based biopharmaceutical company which is engaged in developing novel vaccines and immunotherapies to address diseases with significant unmet needs. Its product candidate includes GEN-003 which is an immunotherapy for the treatment of genital herpes as well as it owns a pre-clinical immuno-oncology program focused on personalized cancer vaccines. The company focuses on developing vaccines and immunotherapies for unmet needs through its AnTigen Lead Acquisition System, which is used to design vaccines and immunotherapies. Genocea operates its business through the single segment being Developing and Commercializing vaccines.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
GNCAQ has been successfully added to your 